Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 275 of 991 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/11/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/10/21
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 04/01/16
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 01/01/09
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 01/21/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 02/03/23
End: 07/15/23
Due: 07/15/24
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 01/05/17
End: 02/28/18
Due: 02/28/19
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 07/11/19
End: 08/31/20
Due: 08/31/21
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 08/01/24
End: 03/17/27
Due: 03/17/28
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 02/18/24
End: 09/20/25
Due: 09/20/26
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 08/31/17
Due: 08/31/18
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase: N/A
Priority: Normal
Start: 05/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 02/25/21
End: 03/10/27
Due: 03/10/28
Phase: N/A
Priority: Normal
Start: 08/20/20
End: 07/31/23
Due: 07/31/24